BRD7: A novel tumor suppressor gene in different cancers

American Journal of Translational Research

Volumn 8, Issue 2, 2016, Pages 742-748

  Yu, Xin ^a   Li, Zheng ^a   Shen, Jianxiong ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

BRD7; Cancers; Tumor suppressor gene

Indexed keywords

ANAPHASE PROMOTING COMPLEX; BETA CATENIN; BRCA1 PROTEIN; BRG1 PROTEIN; CELL CYCLE PROTEIN 20; MICRORNA 200C; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; UVOMORULIN;

BRD7 GENE; BREAST CANCER; CELL PROLIFERATION; COLORECTAL CANCER; ENDOMETRIUM CARCINOMA; GENE EXPRESSION; GLIOMA; HUMAN; MOUTH SQUAMOUS CELL CARCINOMA; NASOPHARYNX CARCINOMA; NEOPLASM; NONHUMAN; ONCOGENE C MYC; OSTEOSARCOMA; OVARY CANCER; PANCREAS CANCER; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 84962128700     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Blagosklonny MV. Molecular theory of cancer. Cancer Biol Ther 2005; 4: 621-627.
2. Zhao H, Wang J, Han Y, Huang Z, Ying J, Bi X, Zhao J, Fang Y, Zhou H, Zhou J, Li Z, Zhang Y, Yang X, Yan T, Wang L, Torbenson MS and Cai J. ARID2: a new tumor suppressor gene in hepatocellular carcinoma. Oncotarget 2011; 2: 886-891.
3. Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK and Zhou MM. Structure and ligand of a histone acetyltransferase bromodomain. Nature 1999; 399: 491-496.
4. Kaeser MD, Aslanian A, Dong MQ, Yates JR, III and Emerson BM. BRD7, a novel PBAFspecific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells. J Biol Chem 2008; 283: 32254-32263.
5. Kzhyshkowska J, Rusch A, Wolf H and Dobner T. Regulation of transcription by the heteroge neous nuclear ribonucleoprotein E1B-AP5 is mediated by complex formation with the novel bromodomain-containing protein BRD7. Biochem J 2003; 371: 385-393.
6. Peng C, Zhou J, Liu HY, Zhou M, Wang LL, Zhang QH, Yang YX, Xiong W, Shen SR, Li XL and Li GY. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain. J Cell Biochem 2006; 97: 882-892.
7. Drost J, Mantovani F, Tocco F, Elkon R, Comel A, Holstege H, Kerkhoven R, Jonkers J, Voorhoeve PM, Agami R and Del Sal G. BRD7 is a candidate tumour suppressor gene required for p53 function. Nat Cell Biol 2010; 12: 380-389.
8. Harte MT, O’Brien GJ, Ryan NM, Gorski JJ, Savage KI, Crawford NT, Mullan PB and Harkin DP. BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription. Cancer Res 2010; 70: 2538-2547.
9. Burrows AE, Smogorzewska A and Elledge SJ. Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proc Natl Acad Sci U S A 2010; 107: 14280-14285.
10. Chen R, Yik JH, Lew QJ and Chao SH. Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer. Biomed Res Int 2014; 2014: 232870.
11. Yu Y, Zhang BC, Xie Y, Cao L, Zhou M, Zhan FH and Li GY. Analysis and Molecular Cloning of Differentially Expressing Genes in Nasopharyngeal Carcinoma. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2000; 32: 327-332.
12. Staal A, Enserink JM, Stein JL, Stein GS and van Wijnen AJ. Molecular characterization of celtix-1, a bromodomain protein interacting with the transcription factor interferon regulatory factor 2. J Cell Physiol 2000; 185: 269-279.
13. Zhou M, Liu H, Xu X, Zhou H, Li X, Peng C, Shen S, Xiong W, Ma J, Zeng Z, Fang S, Nie X, Yang Y, Zhou J, Xiang J, Cao L, Peng S, Li S and Li G. Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression. J Cell Biochem 2006; 98: 920-930.
14. Peng C, Zhou M, Zhang QH, Tang K and Li GY. Analysis of bromodomain of BRD-7 gene and its prokaryotic expression. Ai Zheng 2002; 21: 1167-1172.
15. Wu M, Li X, Li X and Li G. Signaling Transduction Network Mediated by Tumor Suppressor/ Susceptibility Genes in NPC. Curr Genomics 2009; 10: 216-222.
16. Tae S, Karkhanis V, Velasco K, Yaneva M, Erdjument-Bromage H, Tempst P and Sif S. Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes. Nucleic Acids Res 2011; 39: 5424-5438.
17. Yu Y, Zhu S, Zhang B, Zhou M, Li X and Li G. Screening of BRD7 interacting proteins by yeast two-hybrid system. Sci China C Life Sci 2002; 45: 546-552.
18. Zhou J, Ma J, Zhang BC, Li XL, Shen SR, Zhu SG, Xiong W, Liu HY, Huang H, Zhou M and Li GY. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/ MEK/ERK and Rb/E2F pathways. J Cell Physiol 2004; 200: 89-98.
19. Peng C, Liu HY, Zhou M, Zhang LM, Li XL, Shen SR and Li GY. BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways. Mol Cell Biochem 2007; 303: 141-149.
20. Liu H, Zhang L, Niu Z, Zhou M, Peng C, Li X, Deng T, Shi L, Tan Y and Li G. Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells. BMC Cancer 2008; 8: 253.
21. Wu M, Li X and Li G. Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC. Curr Genomics 2009; 10: 216-222.
22. Wang H, Zhao R, Zhou M, Guo C, Liu Y, Jiang S, Li X, Xiong W, Ma J, Peng S, Li X, Schmitt DC, Tan M and Li G. Preparation of polyclonal antibody highly specific for mouse BRD7 protein and its application. Acta Biochim Biophys Sin (Shanghai) 2014; 46: 163-166.
23. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, Maher E, Kaye FJ, Sasaki H, Tepper JE, Fletcher JA, Tabernero J, Baselga J, Tsao MS, Demichelis F, Rubin MA, Janne PA, Daly MJ, Nucera C, Levine RL, Ebert BL, Gabriel S, Rustgi AK, Antonescu CR, Ladanyi M, Letai A, Garraway LA, Loda M, Beer DG, True LD, Okamoto A, Pomeroy SL, Singer S, Golub TR, Lander ES, Getz G, Sellers WR and Meyerson M. The landscape of somatic copy-number alteration across human cancers. Nature 2010; 463: 899-905.
24. Penkert J, Schlegelberger B, Steinemann D and Gadzicki D. No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways. Fam Cancer 2012; 11: 601-606.
25. Pern F, Bogdanova N, Schurmann P, Lin M, Ay A, Langer F, Hillemanns P, Christiansen H, Park-Simon TW and Dork T. Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triplenegative breast cancer. PLoS One 2012; 7: e47993.
26. Zhu B, Tian J, Zhong R, Tian Y, Chen W, Qian J, Zou L, Xiao M, Shen N, Yang H, Lou J, Qiu Q, Ke J, Lu X, Song W, Li H, Liu L, Wang L and Miao X. Genetic variants in the SWI/SNF complex and smoking collaborate to modify the risk of pancreatic cancer in a Chinese population. Mol Carcinog 2015; 54: 761-8.
27. Zhang XM, Wang XY, Sheng SR, Wang JR and Li J. Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer. World J Gastroenterol 2003; 9: 1729-1733.
28. Wu WJ, Hu KS, Chen DL, Zeng ZL, Luo HY, Wang F, Wang DS, Wang ZQ, He F and Xu RH. Prognostic relevance of BRD7 expression in colorectal carcinoma. Eur J Clin Invest 2013; 43: 131-140.
29. Kikuchi M, Okumura F, Tsukiyama T, Watanabe M, Miyajima N, Tanaka J, Imamura M and Hatakeyama S. TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells. Biochim Biophys Acta 2009; 1793: 1828-1836.
30. Park YA, Lee JW, Kim HS, Lee YY, Kim TJ, Choi CH, Choi JJ, Jeon HK, Cho YJ, Ryu JY, Kim BG and Bae DS. Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma. Clin Cancer Res 2014; 20: 565-575.
31. Park YA, Lee JW, Choi JJ, Jeon HK, Cho Y, Choi C, Kim TJ, Lee NW, Kim BG and Bae DS. The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma. Gynecol Oncol 2012; 124: 125-133.
32. Hu K, Liao D, Wu W, Han AJ, Shi HJ, Wang F, Wang X, Zhong L, Duan T, Wu Y, Cao J, Tang J, Sang Y, Wang L, Lv X, Xu S, Zhang RH, Deng WG, Li SP, Zeng YX and Kang T. Targeting the anaphase-promoting complex/cyclosome (APC/C)-bromodomain containing 7 (BRD7) pathway for human osteosarcoma. Oncotarget 2014; 5: 3088-3100.
33. Tang H, Wang Z, Liu Q, Liu X, Wu M and Li G. Disturbing miR-182 and-381 inhibits BRD7 transcription and glioma growth by directly targeting LRRC4. PLoS One 2014; 9: e84146.
34. Kim SJ, Hwang JA, Ro JY, Lee YS and Chun KH. Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer. Oncotarget 2013; 4: 1461-1471.
35. Balasubramanian A, Subramaniam R, Narayanan V, Annamalai T and Ramanathan A. BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas. Asian Pac J Cancer Prev 2015; 16: 1615-1619.
36. Liu H, Zhou M, Luo X, Zhang L, Niu Z, Peng C, Ma J, Peng S, Zhou H, Xiang B, Li X, Li S, He J, Li X and Li G. Transcriptional regulation of BRD7 expression by Sp1 and c-Myc. BMC Mol Biol 2008; 9: 111.
37. Liu H, Peng C, Zhou M, Zhou J, Shen S, Zhou H, Xiong W, Luo X, Peng S, Niu Z, Ouyang J, Li X and Li G. Cloning and characterization of the BRD7 gene promoter. DNA Cell Biol 2006; 25: 346-358.
38. Zhou M, Xu XJ, Zhou HD, Liu HY, He JJ, Li XL, Peng C, Xiong W, Fan SQ, Lu JH, Ouyang J, Shen SR, Xiang B and Li GY. BRD2 is one of BRD7-interacting proteins and its over-expression could initiate apoptosis. Mol Cell Biochem 2006; 292: 205-212.